<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-vaccines-07-00053">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stephenson</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Nicholson</surname>
    <given-names>K.G.</given-names>
   </name>
   <name>
    <surname>Gluck</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Mischler</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Newman</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Palache</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Verlander</surname>
    <given-names>N.Q.</given-names>
   </name>
   <name>
    <surname>Warburton</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Wood</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Zambon</surname>
    <given-names>M.C.</given-names>
   </name>
  </person-group>
  <article-title>Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: Phase I randomised trial</article-title>
  <source>Lancet</source>
  <year>2003</year>
  <volume>362</volume>
  <fpage>1959</fpage>
  <lpage>1966</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(03)15014-3</pub-id>
  <pub-id pub-id-type="pmid">14683655</pub-id>
 </element-citation>
</ref>
